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The patch-clamp open-cell recording configuration has been used to investigate the effects of non-hydrolyzable analogues 
of ATP on the diazoxide-activation of Kirp channels in the insulin-secreting cell line RINmSF. K+ channels inhibited 
by 0.1, 0.5 and 1.0 mM ATP were consistently activated by 200 PM diazoxide. During sustained activation of channels, 
exchange of ATP for either AMP-PNP, AMP-PCP or ATPyS abolished the effects of d&oxide. If d&oxide was added 
to the membrane in the continued presence of AMP-PNP, AMP-PCP or ATPyS either no effects were observed or alterna- 
tively a small transient activation of channels occurred. This study suggests that protein phosphorylation is necessary 
for diazoxide to activate ATP-sensitive potassium channels in insulin-secreting cells. 
Patch clamp; K+ channel; Diazoxide; ATP; (RINmSF cell) 
1. INTRODUCTION 
Control of the gating of ATP-sensitive potas- 
sium channels (KATP channels) in insulin-secreting 
cells plays a fundamental role in the regulation of 
insulin release [1,2]. Carbohydrate-induced closure 
of channels results in the initiation of a depolariza- 
tion of the membrane [3,4]. This depolarization is 
required for the opening of voltage-gated Ca2+ 
channels, which leads to a rise in the intracellular 
Ca2+ concentration, the key intracellular regulator 
of insulin secretion [5,6]. 
Potassium channel modulator compounds, 
especially the novel family of K+ channel openers, 
are becoming increasingly important in the phar- 
macological control of physiological disorders [7]. 
The sulphonamide diazoxide causes hyperglycemia 
in humans, and has therefore been used to treat 
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certain forms of pancreatic insulinomas [S]. 
D&oxide has the opposite effect to glucose; 
hyperpolarizing the cell membrane, thereby abo- 
lishing the glucose-induced release of insulin [9]. 
Through the use of the patch-clamp technique it 
has been shown that d&oxide mediates its effects 
through the selective activation of K~rp channels 
[lO,ll]. However, the mechanism of activation is, 
to some degree unknown, but appears to depend in 
a complex manner upon the presence of cytosolic 
ATP [ll]. 
The present study was undertaken to investigate 
the possibility that protein phosphorylation may be 
important for d&oxide to activate K~rp channels 
in insulin-secreting cells. 
2. METHODS AND MATERIALS 
All experiments were carried out upon the clonal insulinoma 
cell line RINm5F, cultured and prepared as previously described 
14,121. Single-channel currents [13] from ATP-sensitive K+ 
channels were recorded using the open- or saponin- 
permeabilized cell technique, in order to deter the inherent run- 
down of these channels [11,14]. The patch-clamp recording 
pipette was filled with a Na+-rich extracellular type solution 
containing (mM): 140 NaCI, 4.7 KCl, 1.13 MgClr, 2.5 glucose, 
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10 Hepes and 1 EGTA, CaC12 was not added and the pH was 
maintained at 7.2 (NaOH). The bath was filled with a K’-rich 
intracellular type solution containing (mM): 140 KCl, 10 NaCI, 
1.13 MgClz, 2.5 glucose, 10 Hepes and 0.5 EGTA, CaC12 was 
not added and the pH was maintained at 7.2 (KOH). Stock solu- 
tions of d&oxide (Glaxo Research Group, England) were 
prepared in dimethyl sulphoxide (DMSO), which had no effects 
upon KC channels at concentrations up to 1 Vo [l 11. The 
osmolality of all solutions was 290 f 5 mOsmolal/kg. All ex- 
periments were carried out at room temperature (22-25°C). 
Figures showing single-channel current records were obtained 
from pen-recorder traces of single-channel current data stored 
on F.M. tapes (Race1 4DS recorder). Upward deflections repre- 
sent outward current flow (i.e. from the inside to the outside of 
the membrane patch). Channel open probability has been ex- 
pressed as a percentage of the control or pretest level of activity. 
This method of quantification was preferred to that of express- 
ing an absolute value of open-state probability since the 
definitive number of operational channels in a particular patch 
of membrane is often unknown [12]. 
3. RESULTS 
Fig.1 shows a typical RINmSF open-cell re- 
cording, containing openings from several large 
and small ATP-sensitive K+ channels [ 151. Open- 
ings from these channels were abolished when 0.5 
mM ATP is added to the bath solution, which is in 
contact inside of the plasma membrane. In the con- 
tinued presence of ATP, d&oxide (200 PM) 
evokes a marked and sustained activation of ATP- 
inhibited channels. This effect of d&oxide has 
been quantified in 22 separate open-cell recordings 
in which the inside of the plasma membrane had 
been exposed to either 1,0.5 or 0.1 mM ATP, sum- 
marised in fig.2. 0.1 mM ATP was added to 4 
separate patches and found to close K+ channels to 
varying degrees on all 12 occasions (12/12), 0.5 
mM ATP was added to 14 patches (29129) and 1 
ATP 
-_ 
DIAZOXIDE 
mM ATP to 4 patches (9/9). In the continued 
presence of ATP, diazoxide always produced a 
marked and sustained activation of channels; with 
0.1 mM ATP 14/14 applications, 7 of which were 
found suitable for analysis (fig.2A), 49/49 times 
with 0.5 mM ATP (42 of which were analysed) 
(fig.2B) and 24/24 times with 1 mM ATP (10 of 
which were analysed (fig.ZC). In agreement with 
our previous study [l 11, the action of diazoxide was 
more pronounced in the presence of lower (fig.2A) 
rather than higher (fig.2C) concentrations of ATP. 
In contrast to the action of diazoxide on ATP- 
inhibited K+ channels, replacing ATP with ATPyS 
in the continued presence of diazoxide, inhibited 
the response (fig.1). Adding diazoxide in the 
presence of ATPyS had no effect on the channels. 
Only when ATPyS was removed and replaced with 
ATP could diazoxide activate channels (fig.1). 
Finally when ATP is removed the level of activity 
recovers to the pretest value. 
In 9 other open cells, where the same experiment 
was carried out, ATPyS always closed diazoxide- 
activated K+ channels (20/20 applications). Similar 
effects were also obtained for AMP-PNP in 4 other 
patches (12/13 applications), the analysis of 6 of 
these applications is illustrated in fig.3A. 
Adding diazoxide (200 PM) to either AMP-PNP 
(4 patches), AMP-PCP (4 patches) or ATPyS (14 
patches)-inhibited channels had two effects. Either 
the sulphonamide had no significant influence 
upon the channels inhibited by the ATP analogue; 
AMP-PNP (5112 applications), AMP-PCP (4/4 
applications) or ATPyS (9116 applications), shown 
for ATPyS in fig.3C. Alternatively diazoxide 
brought about a brief transient activation of KATZ 
channels; AMP-PNP (7/12 applications) or 
ATP 
DIAZOXIDE 
AT P-v-S 
Fig. 1. The effects of 0.5 mM ATP and 0.5 mM ATPrS upon 200 ,uM d&oxide-activated K ~rp channels in insulin-secreting cells. The 
record shown is taken from a RINmSF open cell, permeabilized with 0.05% saponin, applied to the bath solution, outside the area from 
which the recording is being made [4]. The break in the record corresponds to a 25 s period, during which time the membrane was con- 
tinuously exposed to 0.5 mM ATP. 
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Fig.2. Comparison between the effects of diazoxide upon 0.1 mM (A), 0.5 mM (B) and 1 mM (C) ATP-inhibited K+ channels. Changes 
in the activities of channels have been expressed as a percentage of the pre-control evel of activity (100%). Average values have been 
plotted as means f SE from 7 (A), 42 (B) and 10 (C) experiments. 
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Fig.3. The effects of 1 mM AMP-PNP and 0.5 mM ATPyS on diazoxide-aitivated KATP channels. Average values have been plotted 
as means f SE from 6 (A), 4 (B) and 9 (C) experiments. 
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Fig.4. The action of 1 mM AMP-PNP upon 0.5 mM ATP-sensitive K’ channels activated by 200 PM diazoxide. The breaks in the 
record correspond to a 20 and a 30 s period, respectively, during which time the membrane was continuously exposed to 0.5 mM ATP. 
ATPyS (7/16 applications), as shown for AMP- 
PNP in fig.3B, where 4 of these experiments were 
found suitable for analysis. This transient activa- 
tion of channels, appeared only to follow a period 
of prolonged exposure of the membrane to ATP, 
since as illustrated in fig.4, a second application of 
AMP-PNP (or ATPyS) to the membrane closed 
channels in a manner similar to that seen for 
ATPyS in fig.1. 
4. DISCUSSION 
The experiments presented in this study of the 
mechanism of activation of K~rp channels by 
d&oxide suggest that protein phosphorylation 
must take place in order for the sulphonamide to 
open channels. In previous experiments we have 
shown that ATP, although required by d&oxide, 
will close diazoxide-activated channels [ 111, this 
finding has been confirmed (fig.2). In the con- 
tinued presence of non-hydrolyzable analogues of 
ATP (AMP-PNP, AMP-PCP and ATPyS), 
diazoxide has no significant effects upon K+ chan- 
nels. However, following prolonged exposure of 
the membrane to ATP, a very brief transient ac- 
tivation of channels was sometimes observed. One 
possible explanation for this could be that the tran- 
sient effects reflect the time delay in exchanging the 
analogue for ATP in the nucleotide-binding do- 
main of the channel. Once ATP has been removed, 
channels are inhibited. 
In conclusion these findings would tend to sug- 
gest that either (i) the binding site accessed by ATP 
enabling diazoxide to activate K+ channels, cannot 
be reached by the analogues AMP-PNP, AMP- 
PCP or ATPyS or (ii) that phosphorylation of 
either the KATP channel or its control units is re- 
quired, in order for diazoxide to bind and open the 
channels. Alternatively, it could be argued that 
since interactions between ATP and d&oxide are 
complex, AMP-PNP, AMP-PCP and ATPyS are 
more potent at inhibiting channels and therefore 
close diazoxide-activated channels. However, since 
in both these (figs 2 and 3) and in previous ex- 
periments [16], we have shown that ATP and its 
analogues have very similar efficacies of inhibition, 
this possibility can be dismissed. 
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